Alanine Aminotransferase Repeatability Test: Principles, Protocols, and Performance Evaluation

The alanine aminotransferase (ALT) repeatability test is a core precision study used to verify the consistency of ALT measurements in clinical laboratories. By repeatedly analyzing the same samples under identical conditions, laboratories can quantify within-run imprecision, confirm manufacturer performance claims, and meet accreditation requirements. This article provides a comprehensive technical guide covering assay principles, sample selection, testing protocols, data analysis, and practical applications.

Technical Overview

Alanine aminotransferase (ALT, EC 2.6.1.2), formerly known as serum glutamic-pyruvic transaminase (SGPT), is a key enzyme marker of hepatocellular injury. It catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate, producing pyruvate and L-glutamate. Because ALT measurements directly influence the diagnosis and monitoring of liver disease, hemolysis evaluation, and drug-safety studies, the analytical precision of the assay is critical.

A repeatability test, also referred to as a within-run precision study, evaluates the agreement between repeated measurements of the same sample performed under identical conditions: the same operator, the same instrument, the same reagent lot, the same calibration, and within a short time interval. The result is expressed as the coefficient of variation (CV%), which reflects random analytical error. Repeatability studies are typically designed in accordance with CLSI guidelines such as EP05 and EP15, and they are a mandatory component of method verification under ISO 15189 accreditation.

Testing Samples

Serum and Plasma Specimens

Serum is the preferred specimen type for ALT testing, although lithium-heparin plasma is also widely accepted. Pooled patient serum is frequently used for repeatability studies because its matrix closely resembles authentic clinical samples. Hemolyzed specimens should be avoided, since erythrocyte contents can interfere with the coupled enzymatic reaction and artificially alter results.

Commercial Quality Control Materials

Liquid or lyophilized control materials with assigned target values are commonly used for repeatability verification. At least two concentration levels should be tested: one within the normal reference interval (approximately 30 to 50 U/L) and one at a clinically elevated level (approximately 120 to 200 U/L). Testing near medical decision points ensures that precision is adequate across the range where clinical interpretation occurs.

Sample Handling and Storage

Samples should be mixed gently and brought to the analysis temperature before testing. ALT is reasonably stable in serum for 24 hours at 2 to 8 degrees Celsius and for several days when frozen at minus 20 degrees Celsius or below. Repeated freeze-thaw cycles must be avoided, as they can degrade enzyme activity and inflate the measured imprecision.

Testing Items

The alanine aminotransferase repeatability test evaluates the following parameters:

• ALT catalytic activity in U/L (or microkatal per liter) at each concentration level
• Within-run mean value of replicate measurements
• Standard deviation (SD) of replicate results
• Coefficient of variation (CV%) calculated as SD divided by the mean, multiplied by 100
• Comparison of the observed CV against the manufacturer's imprecision claim and laboratory acceptance criteria
• Optional assessment of bias between the measured mean and the assigned target value of control materials

Testing Methods

Assay Principle

The ALT activity is measured using the International Federation of Clinical Chemistry (IFCC) recommended method at 37 degrees Celsius. ALT converts L-alanine and alpha-ketoglutarate to pyruvate and L-glutamate. The pyruvate is then reduced to lactate by lactate dehydrogenase with simultaneous oxidation of NADH to NAD. The rate of decrease in absorbance at 340 nm is directly proportional to ALT activity. Modern reagent formulations include pyridoxal-5-phosphate to fully activate the enzyme and ensure complete analytical recovery.

Repeatability Testing Protocol

A simplified verification protocol requires a minimum of 20 replicate measurements of each sample level in a single analytical run. For a full precision evaluation following CLSI EP05, the laboratory performs two runs per day with duplicate measurements over 20 operating days, which allows separation of within-run, between-run, and between-day components. During the study, all conditions must remain constant, and no recalibration, reagent lot change, or instrument maintenance should occur unless it is part of the study design.

Data Analysis and Acceptance Criteria

Calculate the mean, SD, and CV% for each concentration level. Obvious outliers should be investigated and handled according to a predefined plan, typically using statistical outlier tests rather than arbitrary exclusion. Many automated ALT methods achieve within-run CVs below 2 to 3 percent at normal and elevated levels. Acceptance limits may be based on the manufacturer's claimed imprecision, regulatory quality specifications, or biological variation data, which suggest a desirable analytical CV for ALT of approximately 6 percent or less. If the calculated CV exceeds the verification limit, the study fails and corrective action is required.

Applications

ALT repeatability testing supports multiple quality assurance and clinical functions in the laboratory:

• Verification of imprecision claims for new ALT reagents, calibrators, or analytical systems before clinical implementation
• Performance confirmation after instrument installation, relocation, or major maintenance
• Support of ISO 15189 and CAP accreditation requirements for method validation and verification
• Monitoring of long-term analytical performance through quality control programs
• Harmonization and comparability studies across multiple instruments or laboratory sites
• Evaluation of assay stability during reagent lot transitions or software updates

FAQ

What is the difference between repeatability and reproducibility?

Repeatability refers to precision under identical conditions, meaning the same operator, instrument, reagent lot, and calibration within a short time period. Reproducibility involves changed conditions, such as different operators, instruments, days, or laboratories, and therefore reflects combined within-laboratory or inter-laboratory variation.

How many replicates are required for a valid repeatability test?

For a basic verification, at least 20 replicates per concentration level are recommended to obtain a statistically reliable estimate of within-run CV. Formal precision studies following CLSI EP05 use a structured design of two runs per day with two replicates each over 20 days.

What level of CV is considered acceptable for ALT?

Acceptance depends on the context, but well-performing automated assays typically demonstrate within-run CVs below 3 percent at normal and elevated concentrations. Goals derived from biological variation suggest that the desirable analytical CV for ALT should be approximately 6 percent or lower.

Why must multiple concentration levels be tested?

Imprecision is not uniform across the measuring range. CV tends to be proportionally larger at low activities, so testing both normal and elevated levels confirms that precision is adequate near the clinical decision limits where results drive patient management.

What should be done if the repeatability test fails?

The laboratory should investigate potential causes such as inadequate mixing, bubble formation, unstable incubation temperature, reagent deterioration, calibration drift, or poor cuvette condition. After corrective maintenance and recalibration, the repeatability study must be repeated until the observed CV meets the acceptance criteria.